These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 6122695)
1. Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia. Chovinard G; Jones B J Clin Psychopharmacol; 1982 Apr; 2(2):143-4. PubMed ID: 6122695 [No Abstract] [Full Text] [Related]
2. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients. Chouinard G; Annable L; Ross-Chouinard A Psychopharmacol Bull; 1986; 22(3):891-6. PubMed ID: 2879310 [No Abstract] [Full Text] [Related]
3. Neuroleptic-induced reinnervation sprouting in the central nervous system (a model for the development of tardive dyskinesia and supersensitivity psychosis). Staton RD; Brumback RA J Clin Psychiatry; 1980 Dec; 41(12 Pt 1):427-8. PubMed ID: 6108320 [No Abstract] [Full Text] [Related]
4. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia. Diamond BI; Borison RL Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312 [No Abstract] [Full Text] [Related]
5. [The concept of supersensitivity psychosis. The particular case of clozapine]. Llorca PM; Penault F; Lançon C; Dufumier E; Vaiva G Encephale; 1999; 25(6):638-44. PubMed ID: 10668609 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder. Steiner W; Laporta M; Chouinard G Acta Psychiatr Scand; 1990 May; 81(5):437-40. PubMed ID: 1972608 [TBL] [Abstract][Full Text] [Related]
7. A therapeutic approach to tardive dyskinesia. Fahn S J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474 [TBL] [Abstract][Full Text] [Related]
8. Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment. Chouinard G Schizophr Res; 1991; 5(1):21-33. PubMed ID: 1677263 [TBL] [Abstract][Full Text] [Related]
9. [Withdrawal symptoms of neuroleptics?]. Mager T Med Monatsschr Pharm; 1994 Aug; 17(8):252. PubMed ID: 7935155 [No Abstract] [Full Text] [Related]
11. [Complications of drug withdrawal from antiparkinson agents and neuroleptics]. Mizon JP; Rosa A Therapie; 1984; 39(4):421-5. PubMed ID: 6148792 [No Abstract] [Full Text] [Related]
12. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity? Jeste DV; Wyatt RJ J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358 [TBL] [Abstract][Full Text] [Related]
13. [Psychosis of supersensitivity or tardive psychosis of neuroleptics. A complication of long-term neuroleptic treatment?]. Bourgeois M Ann Med Psychol (Paris); 1987 Feb; 145(2):161-3. PubMed ID: 2887140 [No Abstract] [Full Text] [Related]
15. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs. Kristjansen P Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796 [No Abstract] [Full Text] [Related]
16. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis. Csernansky JG; Vinogradov S; Prosser E; Kaplan J; Berger PA; Hollister LE Psychopharmacol Bull; 1986; 22(3):897-9. PubMed ID: 2879311 [No Abstract] [Full Text] [Related]
17. Supersensitivity psychosis in a case with clozapine tolerance. Ozcan S; Soydan A; Tamam L Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():70-3. PubMed ID: 23090814 [TBL] [Abstract][Full Text] [Related]